Sopharma Trading AD

DB:6YH Stock Report

Market Cap: €87.6m

Sopharma Trading AD Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Ventsislav Marinov

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownership0.05%
Management average tenureless than a year
Board average tenureno data

Recent management updates

Recent updates

CEO

Ventsislav Marinov

less than a year

Tenure

Mr. Ventsislav Stefanov Marinov serves as Chief Executive Officer & Director at Sopharma Trading AD since November 2021. He served as Chief Strategy Execution Officer at Sopharma Trading AD since July 2018...

Leadership Team

NamePositionTenureCompensationOwnership
Ventsislav Marinov
CEO & Directorless than a yearno data0.046%
€ 40.4k
Petya Angelova
Chief Financial Officer1.3yrsno datano data
Dimitar Bogomilov
Member of Management Boardno datano datano data
Antoaneta Georgieva
Member of Management Boardno datano datano data
Prolet Kostova
Chief Innovation Officer & Member of Management Boardno datano datano data
Alexandar Yotov
Member of Management Boardno datano datano data
Denitsa Georgieva
Director of Technology & Business Solutions and Member of Management Boardno datano datano data
Georgi Hristov
Director Supply Chain Management & Operations1.5yrsno datano data
Teodomir Tsvetkov
Chief Accountantno datano datano data
Maya Taseva
Chief Human Resources Officerno datano datano data
Budimir Sanic
Chief Executive Officer of Sopharma Trading Serbialess than a yearno datano data

1.0yrs

Average Tenure

Experienced Management: 6YH's management team is not considered experienced ( 1 years average tenure), which suggests a new team.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2022/07/06 03:10
End of Day Share Price 2022/04/08 00:00
Earnings2022/03/31
Annual Earnings2021/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sopharma Trading AD is covered by 1 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mihail DimitrovFirst Financial Brokerage House